<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Frailty in cancer</dc:title><dc:creator>Čavka,	Luka	(Avtor)
	</dc:creator><dc:creator>Laviano,	Alessandro	(Avtor)
	</dc:creator><dc:creator>Lainščak,	Mitja	(Avtor)
	</dc:creator><dc:subject>cancer</dc:subject><dc:subject>frailty</dc:subject><dc:subject>outcome</dc:subject><dc:description>Every era of medicine faces unique challenges. Today, aging is atthe forefront, with the global population over 65 years expectedto rise from 9% in 2019 to 17% in 2050. With this demographicshift, we must address the specific limitations of older adults,particularly frailty</dc:description><dc:date>2025</dc:date><dc:date>2026-05-26 11:05:08</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>182865</dc:identifier><dc:identifier>UDK: 616-006</dc:identifier><dc:identifier>ISSN pri članku: 2190-5991</dc:identifier><dc:identifier>DOI: 10.1002/jcsm.70139</dc:identifier><dc:identifier>COBISS_ID: 261089539</dc:identifier><dc:language>sl</dc:language></metadata>
